Erik Harris - Net Worth and Insider Trading

Erik Harris Net Worth

The estimated net worth of Erik Harris is at least $3 Million dollars as of 2025-03-04. Erik Harris is the EVP & Chief Commercial Officer of Ultragenyx Pharmaceutical Inc and owns about 67,163 shares of Ultragenyx Pharmaceutical Inc (RARE) stock worth over $3 Million. Details can be seen in Erik Harris's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Erik Harris has not made any transactions after 2024-03-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Erik Harris

To

Erik Harris Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Erik Harris owns 2 companies in total, including Ultragenyx Pharmaceutical Inc (RARE) , and Denali Therapeutics Inc (DNLI) .

Click here to see the complete history of Erik Harris’s form 4 insider trades.

Insider Ownership Summary of Erik Harris

Ticker Comapny Transaction Date Type of Owner
RARE Ultragenyx Pharmaceutical Inc 2024-03-01 EVP & Chief Commercial Officer
DNLI Denali Therapeutics Inc 2022-02-03 director

Erik Harris Latest Holdings Summary

Erik Harris currently owns a total of 1 stock. Erik Harris owns 67,163 shares of Ultragenyx Pharmaceutical Inc (RARE) as of March 1, 2024, with a value of $3 Million.

Latest Holdings of Erik Harris

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RARE Ultragenyx Pharmaceutical Inc 2024-03-01 67,163 40.60 2,726,818

Holding Weightings of Erik Harris


Erik Harris Form 4 Trading Tracker

According to the SEC Form 4 filings, Erik Harris has made a total of 14 transactions in Ultragenyx Pharmaceutical Inc (RARE) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in Ultragenyx Pharmaceutical Inc is the sale of 4,768 shares on March 1, 2024, which brought Erik Harris around $256,328.

Insider Trading History of Erik Harris

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Erik Harris Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Erik Harris Ownership Network

Ownership Network List of Erik Harris

No Data

Ownership Network Relation of Erik Harris

Insider Network Chart

Erik Harris Owned Company Details

What does Ultragenyx Pharmaceutical Inc do?

Who are the key executives at Ultragenyx Pharmaceutical Inc?

Erik Harris is the EVP & Chief Commercial Officer of Ultragenyx Pharmaceutical Inc. Other key executives at Ultragenyx Pharmaceutical Inc include EVP and General Counsel Karah Herdman Parschauer , director & 10 percent owner & President & CEO Emil D Kakkis , and Chief Financial Officer Howard Horn .

Ultragenyx Pharmaceutical Inc (RARE) Insider Trades Summary

Over the past 18 months, Erik Harris made 2 insider transaction in Ultragenyx Pharmaceutical Inc (RARE) with a net sale of 10,768. Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 167,853 shares made by Emil D Kakkis , a net sale of 52,398 shares made by Thomas Richard Kassberg , and a net sale of 16,552 shares made by Karah Herdman Parschauer .

In summary, during the past 3 months, insiders sold 22,990 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 22,990 shares. During the past 18 months, 278,054 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 278,054 shares.

Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ultragenyx Pharmaceutical Inc Insider Transactions

No Available Data

Erik Harris Mailing Address

Above is the net worth, insider trading, and ownership report for Erik Harris. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Erik Harris's mailing address is: Novato Ca 94949.